XDx Announces Anthem Blue Cross and Blue Shield Has Determined That AlloMap Is Medically Necessary for Heart ...
XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive gene expression tests to monitor immune-mediated conditions, today announced that Anthem Blue Cross and Blue Shield, one of the nation's leading providers of healthcare insurance, has determined that AlloMap is medically necessary as a non-invasive ...

Blue Cross Blue Shield to expand Medicaid program
Blue Cross Blue Shield of Michigan is beginning to carry out a plan to expand its Medicaid product line, which has been small compared with the health insurer's overall 70 percent market share in the state.